Kala Pharmaceuticals

Band of biotechs cut pipeline prospects to focus cash on priority programs
Band of biotechs cut pipeline prospects to focus cash on priority programs
Fierce Biotech
ProQR Therapeutics
Harpoon Therapeutics
Kala Pharmaceuticals
Synthetic Biologics
Flag link:
AcelRx to Buy Lowell Therapeutics; Kala Expands Pipeline with Combangio Acquisition
AcelRx to Buy Lowell Therapeutics; Kala Expands Pipeline with Combangio Acquisition
BioSpace
AcelRx
Kala Pharmaceuticals
M&A
Lowell Therapeutics
Combangio
Flag link:
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
BioSpace
dry eye disease
Novartis
Allergan
Sun Pharma
Bausch
Kala Pharmaceuticals
Flag link:
Kala Gets the Greenlight from FDA for Dry Eye Disease Treatment
Kala Gets the Greenlight from FDA for Dry Eye Disease Treatment
BioSpace
Kala Pharmaceuticals
FDA
Eysuvis
dry eye disease
Flag link:
Go or no go? Vaccine panel upstages US approval decisions
Go or no go? Vaccine panel upstages US approval decisions
EP Vantage
FDA
vaccines
COVID-19
advisory panel
Eysuvis
Brilinta
Kala Pharmaceuticals
dry eye disease
Regeneron
AstraZeneca
stroke
Flag link:
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
Flag link:
FDA wants additional data on Kala Pharma’s KPI-121
FDA wants additional data on Kala Pharma’s KPI-121
Pharma Letter
Kala Pharmaceuticals
KP-121
dry eye disease
FDA
Flag link:
Go or no go? Abbvie, Roche and Kala await key decisions
Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
FDA
AbbVie
upadacatinib
Roche
Ignyta
entrectinib
Kala Pharmaceuticals
KPI-121
dry eye disease
Flag link:
FDA sets summer PDUFA dates for Acer, Kala therapies
FDA sets summer PDUFA dates for Acer, Kala therapies
BioCentury
FDA
Acer Therapeutics
Kala Pharmaceuticals
Edsivo celiprolol
KPI-121
Flag link:
Kala seeks FDA nod for dry eye disease drug
Kala seeks FDA nod for dry eye disease drug
Drug Delivery Business News
Kala Pharmaceuticals
FDA
KPI-121
dry eye disease
Flag link:
FDA approves Kala's twice-daily ocular steriod
FDA approves Kala's twice-daily ocular steriod
BioCentury
Kala Pharmaceuticals
Inveltys
ocular steriods
eye health
Flag link:
Kala Pharma reveals mixed Ph3 data for dry eye disease drug
Kala Pharma reveals mixed Ph3 data for dry eye disease drug
Drug Delivery Business News
Kala Pharmaceuticals
dry eye disease
KPI-121
Flag link:
Kala Pharmaceuticals prices $90m IPO
Kala Pharmaceuticals prices $90m IPO
Drug Delivery Business News
Kala Pharmaceuticals
IPOs
cataract surgery
Flag link:
FierceBiotech's 2013 Fierce 15
FierceBiotech's 2013 Fierce 15
Fierce Biotech
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
Flag link:
Kala Pharmaceuticals Co-founder Publishes Data on Novel Therapeutic Approach to Overcome Mucosal Barrier for Prevention of Herpes Simplex Virus-2 Infection
Kala Pharmaceuticals Co-founder Publishes Data on Novel Therapeutic Approach to Overcome Mucosal Barrier for Prevention of Herpes Simplex Virus-2 Infection
PharmaLive
Kala Pharmaceuticals
herpes
herpes simplex 2
Flag link: